Indicators

Markets:

News

Latest News about AstraZeneca PLC

Recent news which mentions AstraZeneca PLC

< Previous 1 2 3 4 5 Next >

CNBC's Inside India newsletter: A slowing economy hasn't dimmed India's allure at Davos

January 23, 2025

Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

January 17, 2025

J&J says its lung cancer drug combination keeps people alive longer

January 07, 2025

Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal

December 18, 2024

Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data

December 05, 2024

Friday's big stock stories: What’s likely to move the market in the next trading session

November 14, 2024

Cramer's Lighting Round: 'I'm not going to recommend' Altria

November 14, 2024

Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy

November 13, 2024

The 2 things that will drive the stock market after last week's Trump-Fed rally

November 10, 2024

Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca

November 08, 2024

Merck says experimental RSV treatment protected infants in trial, paving way for potential approval

October 17, 2024

Cerebras IPO has 'too much hair' as AI chipmaker tries to sell Wall Street on Nvidia alternative

October 11, 2024

Drugmakers bet billions that targeted radiation could become the next cancer breakthrough

September 16, 2024

AstraZeneca shares fall 5% on disappointing lung cancer drug trial results

September 10, 2024

AstraZeneca says staff detained in China amid reports of a drug-import investigation

September 05, 2024

India and Singapore agree to cooperate on chips as countries seek to strengthen partnership

September 05, 2024

India's Modi expected to usher in new era of bilateral agreements in Singapore visit

September 03, 2024

Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations

August 15, 2024

Healthy Returns: The first round of Medicare drug price negotiations is nearing an end

July 23, 2024

Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big

June 07, 2024

Why CEO AstraZeneca believes the pharmaceutical company can almost double revenues by 2030

June 04, 2024

Cramer's Lighting Round: 'You've got a winner' with Astra Zeneca

May 31, 2024

This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A

May 23, 2024

AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines

May 21, 2024

Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance

May 07, 2024

FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic

April 30, 2024

Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion

April 03, 2024

Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients

March 26, 2024

Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations

March 13, 2024

Judge rejects AstraZeneca’s challenge to Medicare drug price negotiations

March 01, 2024

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.